Maria D. Chaparro
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 260 publications
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
Journal: Journal of Crohn's & colitis
Published: July 07, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
Journal: Journal of Crohn's & colitis
Published: July 01, 2026
Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry.
Journal: Journal of Crohn's & colitis
Published: March 26, 2026
Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumab.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 02, 2026
Evaluation of Long-Term Outcomes of Crohn's Disease Complicated by Intra-Abdominal Abscess: A Retrospective International Cohort Study.
Journal: Journal of clinical medicine
Published: February 17, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.
Journal: United European gastroenterology journal
Published: February 01, 2026
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU.
Journal: Therapeutic advances in gastroenterology
Published: January 28, 2026
The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 13, 2025
Evaluating the Immunological Impact of Hepatitis B Vaccination in Patients with Inflammatory Bowel Disease.
Journal: International journal of molecular sciences
Published: December 12, 2025
Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease.
Journal: Journal of Crohn's & colitis
Published: November 20, 2025
Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU.
Journal: Journal of Crohn's & colitis
Published: November 19, 2025
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study.
Journal: Medicina (Kaunas, Lithuania)
Published: November 05, 2025
Last Updated: 09/26/2026